A patient with COPD comes in with more coughing, sputum, or shortness of breath than usual. Is this actually a COPD exacerbation? Can you safely manage them outpatient? And do they need antibiotics?
In this updated COPD exacerbation guide for nurse practitioners, I walk through a practical approach to evaluating and treating acute COPD exacerbations in primary care using the latest GOLD guidance.
We’ll cover how to recognize a COPD exacerbation (and what else could be causing the patient's symptoms), assess severity, decide when outpatient management is appropriate, and treat an exacerbation with short-acting bronchodilators, systemic corticosteroids, and—when indicated—antibiotics.
You'll also find my original COPD exacerbation case study below, where we apply many of these concepts to a patient visit from start to finish (with some content updates).
Want a quick desk reference for this topic? Grab the COPD Exacerbation and COPD Management cheat sheets in the Digital NP Binder.
Listen - podcast release 10/8/26
Watch
In this episode, you’ll learn:
How to recognize a COPD exacerbation—and what else to consider before assuming COPD is causing the patient's symptoms
How to assess exacerbation severity and decide whether a patient can be safely managed outpatient
When to use short-acting bronchodilators and systemic corticosteroids
How to decide whether antibiotics are indicated (and why increased sputum alone isn't enough)
Which patient factors increase the risk of poor outcomes or Pseudomonas
How soon to reassess a patient after outpatient treatment
What to revisit in the patient's long-term COPD management after the exacerbation
Key Takeaways
Don't Assume It's a COPD Exacerbation: Worsening cough, dyspnea, or sputum in a patient with COPD isn't automatically an exacerbation. Consider other or concurrent causes, including pneumonia, viral infection, heart failure, pulmonary embolism, ACS, arrhythmia, and pneumothorax.
Decide How Sick They Are: Assess dyspnea, respiratory rate, heart rate, oxygenation, mental status, hemodynamic stability, and overall clinical presentation to determine whether outpatient management is appropriate or the patient needs a higher level of care.
Treatment Depends on Severity: Increase short-acting bronchodilator therapy (SABA and/or SAMA) during an exacerbation. For moderate exacerbations, current GOLD guidance recommends prednisone 40 mg daily for 5 days, with antibiotics when indicated.
Don't Automatically Reach for Antibiotics: Not every COPD exacerbation needs antibiotics—and increased sputum alone isn't enough. Consider sputum purulence alongside other clinical features, prior cultures, risk factors for poor outcomes, Pseudomonas risk, and local resistance patterns.
Don't Forget the Follow-Up: Reassess patients treated outpatient within 48–72 hours. Once the acute exacerbation improves, revisit their baseline COPD treatment and exacerbation history to determine whether their maintenance regimen needs to change.Start With the Patient's Baseline
A COPD exacerbation is an acute worsening of dyspnea and/or cough and sputum over a few days, up to 14 days, sometimes accompanied by tachypnea and/or tachycardia. Ask what the patient's breathing, cough, sputum, activity tolerance, and rescue-inhaler use are normally like—and what's different now.
Need a Quick Reference for COPD Visits?
The COPD Exacerbation Cheat Sheet walks you through recognizing an exacerbation, assessing severity, treatment, antibiotics, and when to escalate care.
For ongoing COPD care, the COPD Management Cheat Sheet helps you work through assessment, maintenance treatment, monitoring, and preventive care.
Original COPD Exacerbation Case Study
Want to see the clinical reasoning applied to an actual patient visit? In this original case study, I walk through a patient presenting with worsening COPD symptoms, including how I assess her baseline, decide whether outpatient treatment is appropriate, think through antibiotics, and plan follow-up.
A quick note before you watch: This episode was recorded before the current GOLD guidance. The overall clinical reasoning approach is still useful, but some guideline-specific recommendations have changed. Don't use the ABCD classification/maintenance medication table, vaccination recommendations, or lung cancer screening recommendations in this older episode as current guidance. For current COPD exacerbation recommendations, use the updated episode above and the current GOLD guidelines.
Resources mentioned in this episode:
If you liked this post, also check out:
-
Liz Rohr (they/she) | Real World NP (00:01.568)
Welcome to the Real World NP podcast, where we share practical clinical education, real-world practice insights, and honest conversations to help nurse practitioners feel more confident, capable, and supported in practice. Real World NP is an ANCC accredited continuing education company supporting nurse practitioners, schools, clinics, and fellowship programs in bridging the gap between graduate education and real-world practice. Welcome to this week's episode.
We're going to be talking about COPD exacerbations. So, this is a follow-up of the other episode that I did about COPD management when it comes to the updates of 2025 to 2026. And of note, there's a cheat sheet that goes along with this episode as well as this last episode about COPD inside the digital NP binder. So if you want to grab a copy of that, the description will be below. It's at realworldnp.com/slash binder, and that you can print out, keep at your desk.
is really just a summation of quick points so that it's you can quickly reference it. And the reason I made the binder was that I didn't have the time or the brain capacity to make these quick reference documents when I was a new grad, but I desperately wanted them. because even as an experienced clinician, I'm like, wait, what is the gold criteria? What do the guidelines say again? and I want to be able to have that quickly at my fingertips without kind of rifling through the millions of pages of up to date or
other guidelines or things like that. So anyway, you also can reference the gold guidelines and the gold pocket guidelines, which will also be linked down below. So let's talk about COPD exacerbations. So in the context of a patient visit, this is how I approach COPD exacerbations. And also here are some I'm gonna share some updates in the context of the newest guidelines. So I have another episode about COPD exacerbations and a lot of it is similar, but I just I wanted
Just make this a clean update. So you have a patient that comes into your visit and they're having shortness of breath and they're having like a junky cough and they're feeling like they need antibiotics. That's what they're coming in for as a chief complaint. For example, in the last episode, when I talked about do we actually have a COPD diagnosis here? It's helpful to just quickly look at the chart for a patient like this if you haven't met them before or if you're covering for another provider or if they're a new patient. What records do we have of their last PFTs? Have they ever seen
Liz Rohr (they/she) | Real World NP (02:19.214)
pulmonology before, what medications are they taking, when were they last seen, and just kind of doing a general review of the chart. So do we know that they have a diagnosis of COPD to begin with, right? Because if somebody comes in with shortness of breath and a purulent cough, we don't necessarily know that it's a COPD exacerbation.
Having a previous diagnosis of that helps, but we can further back that information up by looking at the PFTs and understanding where they're at in their disease process. Again, I go, I talk about that in the other episode if you want support with that. So the first thing I'm gonna do when I have this patient in the room, in addition to confirming the diagnosis by doing that quick look at their chart of COPD, I'm gonna think about what is their actual diagnosis right now. Instead of assuming that it's a COPD exacerbation, I'm gonna think about what are the other reasons somebody might have an acutely increased cough.
Purulin sputum, like this person is reporting, and go from there. Some of the alternative or concurrent differentials that we need to think about are things like other, you know, respiratory infections, like do they have influenza, do they have COVID-19? Do they have RSV by chance, heart failure, acute coronary syndrome or MI, arrhythmias, pulmonary embolism, pneumonia, and pneumothorax? That is not a comprehensive list, but those are the things that I'm thinking about.
And so I'm going to do look for some clues, right? So I'm going to think about things like fever, chills, night sweats, peluritic or ischemic chest pain, periphal edema, focal or bibasilar fine crackles. And I'm looking at my notes over here if you see my eyes starting off to the side. So those are the things I'm gonna think about when I first come into the room. Is this a C OBD exacerbation or it's some of these other things? Do they have the red flags that means that they need to get a higher level of care, or can we continue to manage them outpatient?
Reasons we want to send patients to a higher level of care than primary care, like the ED, most likely, is if they have severe dysphmia, especially if if it's at rest, if they have accessory muscle use, altered mental status, cyanosis, hemodynamic instability or hypotension, signs of acute respiratory failure, if they have a new edema or suspicion of an acute heart failure or arrhythmia, or they have a failure to improve with their initial treatment if this is the second time they're being seen.
Liz Rohr (they/she) | Real World NP (04:26.026)
Or if they don't have enough support at home. Like you might be able to manage them outpatient, manage this outpatient, but they, if they don't have enough home support, they might need additional care in the ER. So those are things that I'm looking at right away. The next piece I want to do is if I'm suspecting that this is a COPD exacerbation, what is the diagnostic criteria for that? So the definition, and I'm just gonna take this straight from the guidelines, it's an exacerbation of COPD is an acute event with symptoms worsening over a few days, up to 14 days.
And is characterized by increased dysphia and/or cough and sputum that may be accompanied by tachytmia and/or tachycardia. It's often associated with increased local and systemic inflammation caused by infection, pollution, or other insult to the airways. So before what it used to be, it was sort of like you have two out of three of the criteria that you could meet. Really, we're just gonna suspect it in anybody who has those symptoms less than or equal to 14 days of worsening of cough, dysphemia.
Plus or minus sputum, and we're going to do an assessment of what's going on, thinking about our differentials and what else could be causing this or happening at the same time. So in the guidelines, it gives us this criteria for assessing the severity. So I talk about this a bit in the last episode about COPD management. When it comes to exacerbations, we want to be able to assess if it's mild, moderate, or severe, because that's going to help us in the f not not just now, but in the future.
Help us understand what their ongoing maintenance is. What we're going to be doing for assessing all mild, moderate, to severe is we're going to look at their dyspia. And so it recommends doing a visual analog scale. And so it didn't have one in the guidelines. I just kind of found one and that was corresponding with dysmia. It's basically on a scale of one to 10 on that visual analog scale. And if it's less than five in terms of their dyspia, their respirate is less than 24 breaths per minute, their heart rate is less than 95.
And their resting oxygen is greater than or equal to 92 on either rhomeir or their baseline oxygen. And there's a change of less than or equal to 3% when we know the baseline from before. There is some information about obtaining a CRP, but that's generally not recommended. So I'm not even gonna get into that. And then moderate is basically that plus worse, right? So we're talking about the dyspia visual analog scale of greater than five, resp rate is greater than 24.
Liz Rohr (they/she) | Real World NP (06:42.626)
Heart rate is greater than 95, their resting oxygen is less than 92% on either rhomere or their baseline oxygen, and or there's a change of greater than 3% in their oxygen percentage. And again, the CRP is slightly more elevated, but I'm not even going get into that. And then severe is basically anything worse than that. So it's the same criteria, only we have some concerns for hypoxemia or decompensation. Maybe you get an ABG outpatient, but most patients, most
Providers are not doing that in primary care. So if you're suspecting they need an ABG, they need to go to the ER. I'm sorry to tell you. Cause then nobody wants to send anybody to the ER. When it comes to the management principles, again, this so if we're first looking at triage, red flags, and differential diagnosis, we're thinking about do they need further workout for some of those other underlying etiologies? Do we need a chest x-ray? Do we need a CBC with differential? Do we need to test for COVID and flu? Should we do a Wells criteria or a D-dimer for suspecting a PE?
Slash, do we need to send them to the ER? And then after we've done that triage and differential assessment and we've assessed the severity, if they're in the mild category, we can increase their SABA and or SAMA therapy, which is that short-acting bronchodilators, and increase the dose and frequency during that exacerbation. If they're in the moderate category, though, it's recommended, still recommended, to do a burst of prednisone treatment.
with 40 milligrams orally, daily for five days, plus or minus antibiotics, in addition to the mild treatment of increasing the Saba and or Sama therapy. The the rationale for who needs antibiotics is the main thing I want you to take away from this is use your judgment and be judicious that not everybody gets antibiotics. In the guidelines it says the at least two of increased dyspia, fever,
Increased sputum volume. And if they have that increased sputum volume, is there also increased sputum purulence? Or do they have a prior positive sputum culture during an exacerbation? And again, that's a lot to remember. This is on the criteria, this is on the cheat sheet as well as in the gold guidelines, but it's just a little bit more, a little bit more prescriptive this time than it used to be. So we really just again, it's just getting a little bit more judicious, a little bit more cautious with our antibiotic use.
Liz Rohr (they/she) | Real World NP (08:54.806)
and it's not like a guarantee that, just because you have increased sputum doesn't necessarily mean that you need antibiotics. If they have increased sputum, they also need to have increased purulence in addition to one other thing. And when it comes to the antibiotics, the guidelines are not very prescriptive when it comes to the recommendations of treatment. Expert level of opinion in various other resources, things like up to date or dynamed, have categorization, a little bit more of an algorithm that they follow. The main thing I want you to take away from this is
We want to assess their risk for poor outcomes. So is their FEV one less than 50%? Are they in that gold three category? Do they have two or more exacerbations per year or hospitalizations in the last year? Do they use oxygen or and do they have other comorbidities, especially known cardiovascular comorbidities? We also want to assess their risk for Pseudomonas if they have an FEV one of less than 30, so in that four category, gold's level four, or if they've previously had Pseudomonas, as well as do they have bronchiactasis as well as chronic.
Glucocorticoid use. So those are going to need a slightly different regimen versus if they don't have any of those things, are they more in that typical category? And the main thing to that's also changed in the guidelines, even though they're not prescriptive about the type of antibiotics to use, the recommendation is about five days. So instead of that seven to 10 days, it's recommended to do a complete course of five days and some places even say three days, but five days is about the average. So it kind of makes dosing a little bit easier for patients.
Five days of prednisone and five days of antibiotics. So again, the things I'm citing right now are based on those 2025, 2026 guidelines. The general approach basically remains the same. It's really those treatment principles that have sort of adjusted and shifted. And so the other thing that the guidelines mention about antibiotics is it has to do with your local resistance patterns, which is getting a little bit into the weeds. And so if that's that is something I would consider to look at is your local antibiogram.
Which like I feel like is a little bit tricky to find, but you can always ask your supervisor about their prescribing recommendations when it comes to finding the appropriate antibiotics for patients. One r main pearl though I wanna I wanna add in addition to exacerbations, it's not just about treating the exacerbations. We really wanna reassess the response within f 72 hours, 48 to 72 hours. And if they're not improving or if they're worsening, do they need to be reassessed outpatient or are they getting to a severe point where they need to be going to the ER?
Liz Rohr (they/she) | Real World NP (11:16.078)
for more support. Again, using your clinical judgment of do they have support enough at home? And then after exacerbation, we want to make sure that they're doing better, but we also want to bring them back in in short order to be able to assess their baseline regimen, to understand where this came from. Do they need further support to help prevent further exacerbations, to bring them back into that A B category of their COPD? I think that's potentially a common pitfall that I probably did when I was a new grad is not necessarily have on the books a plan to follow up.
And make sure that I'm adjusting their ongoing treatment regimen, even if it's not your patient and you're covering or if it's an urgent care, definitely recommending that patients make a follow-up appointment because they likely need to adjust their baseline therapy. So that's it for this episode. Hopefully this was helpful. Again, you can check out the cheat sheet that I made to go us along with both these COPD episodes inside the digital NP binder at realworldnp.com/binder, as well as consult the new gold guidelines for COPD management as well as exacerbation management.
Click Here for Your Ultimate Resource Guide for the New NP
Snag our favorite, time-saving, evidence-based resources to help you take the best care of your patients (while keeping your sanity). PLUS you'll get helpful articles, podcasts, and YT video episodes sent to your inbox every week or so.
© 2026 Real World NP. For educational and informational purposes only, see realworldnp.com/disclaimer for full details.
